跳至主要内容
临床试验/NCT02276755
NCT02276755已完成3 期

Vitamin D in TB Prevention in School Age Children

Harvard School of Public Health (HSPH)1 个研究点 分布在 1 个国家目标入组 8,851 人开始时间: 2015年9月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
8,851
试验地点
1
主要终点
Acquisition of latent tuberculosis infection

研究概览

简要总结

The goal of this clinical trial is to determine whether vitamin D supplementation reduces risk of acquiring latent tuberculosis infection (LTBI) in school age children in Mongolia. The investigators hypothesize that (1) vitamin D supplementation will reduce risk of acquisition of LTBI, (2) vitamin D supplementation will safely reduce risk of developing active TB and improve other secondary efficacy outcomes, and (3) children with the lowest vitamin D status at baseline will gain most from the intervention.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 13 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Boys or girls aged 6 to 13 years at enrolment
  • Attending participating school in Ulaanbaatar at enrolment
  • Child gives informed assent to participate in the study
  • Child's parent/legal guardian gives informed consent for child to participate in study

排除标准

  • Chronic medical conditions
  • Presence of LTBI on screening, as evidenced by a positive QFT-G
  • Clinical signs of rickets, or diagnosis of any other condition requiring vitamin D supplementation
  • Known primary hyperparathyroidism or sarcoidosis
  • Taking immunosuppressant or cytotoxic therapy, or vitamin D supplement > 400IU / day
  • Plans to move away from study area within 3 years of enrolment

结局指标

主要结局

Acquisition of latent tuberculosis infection

时间窗: Three years

The proportion of children who acquire LTBI during the 3 year period will be compared for children randomized to vitamin D3 vs. placebo using the Mantel-Haenszel risk ratio, stratified by school of attendance. The primary analysis will compare the proportion of children who are QuantiFERON-positive at the 0.35 IU/ml IFN-gamma threshold at the end of the study. Exploratory analyses will compare the proportion of children who are positive at the 4.0 IU/ml IFN-gamma threshold (denoting stable conversion) and mean / median antigen-stimulated IFN-gamma concentration analyzed as a continuous variable.

次要结局

  • Incidence of active TB disease(Three years)
  • Number of days off school (total number and number due to acute respiratory infection)(Three years)
  • Incidence of acute respiratory infection requiring hospitalization(Three years)
  • Incidence of acute asthma exacerbation requiring hospitalization(Three years)
  • Incidence of new asthma, allergic rhinitis and atopic dermatitis(Three years)
  • Muscle strength: grip strength and long jump distance from standing(Three years)
  • Exam performance(Three years)
  • Self-reported pubertal development(Three years)
  • Urinary metabolome profile(Three years)
  • Gut microbiome profile(Three years)
  • Incidence of acute respiratory infections requiring antibiotic treatment(Three years)
  • Anthropometric outcomes (z-scores for height-for-age, weight-for-age, weight-for-height, body mass index-for-age, and waist circumference and waist-to-height ratio)(Three years)
  • Circulating and antigen-stimulated concentrations of cytokines, chemokines and other inflammatory mediators(Three years)
  • Incidence of self-reported acute respiratory infection (upper, lower and both combined)(Three years)
  • Body composition: impedance, impedance%, fat mass fat %, and fat-free mass(Three years)
  • Physical fitness (maximal oxygen consumption estimated from 20m shuttle run)(Three years)
  • Attention-related behavior scores (Connors III)(Three years)
  • Incidence of dental caries(Three years)
  • Spirometric lung volumes (FEV1 and FVC)(Three years)
  • Serum 25-hydroxyvitamin D concentration(Three years)
  • Control of asthma, allergic rhinitis and atopic dermatitis(Three years)
  • Incidence of bone fracture(Three years)
  • Bone mineral density at the radius(Three years)

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ganmaa Davaasambuu

Assistant Professor

Harvard School of Public Health (HSPH)

研究点 (1)

Loading locations...

相似试验

Vitamin D Supplementation in TB Prevention | 临床试验